GLENMARK vs IPCALAB — stock comparison
Glenmark Pharmaceuticals Ltd (GLENMARK) vs Ipca Laboratories Ltd (IPCALAB): price, valuation, ROE, margins and Traddx's fundamentals grade, side by side. Live NSE/BSE data.
On Traddx's fundamentals score, GLENMARK grades higher (A 86 vs B+ 74). Not investment advice.
1-year price performance — higher line = stronger return
■ GLENMARK +17.4%■ IPCALAB +47.5%Past year, both rebased to 100
| GLENMARK | IPCALAB | |
|---|---|---|
| Traddx grade | A (86) | B+ (74) |
| Price | ₹2,288.95 | ₹1,946.15 |
| Today | 0.32% | -0.27% |
| P/E | 21.00 | 35.90 |
| ROE | 23.60% | 15.70% |
| Net margin | 30.21% | 17.61% |
| Debt / equity | 0.06 | 0.10 |
| 52-week high | ₹2,536.85 | ₹2,039.30 |
| 52-week low | ₹1,794.00 | ₹1,252.95 |
Green = the stronger figure on each row (lower is better for P/E and debt; higher for the rest). Grade is Traddx's own fundamentals score.